Jefferies keeps MannKind at hold

Jefferies & Co., Inc. analyst Adam Walsh kept MannKind Corp. at a hold based on management's tone on its earnings per share loss of $1.23 and the $500 million shelf filing. Walsh said that he believes that a potential partnership deal is not imminent and terms are likely the sticking point, adding that the hold rating reflects a possible upcoming financing, decreased likelihood of a near-term partnership and long-term milestones. Shares of the Valencia, Calif.-based biopharmaceutical company were down 7 cents, or 0.41%, at $17.11. (Nasdaq: MNKD)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.